ENFORTUMAB VEDOTIN

ENFORTUMAB VEDOTIN was reported 7851 times

ENFORTUMAB VEDOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRANSITIONAL CELL CARCINOMA METASTATIC 41 0.3504
1 TRANSITIONAL CELL CARCINOMA RECURRENT 14 0.2414
2 MICROCOCCAL SEPSIS 4 0.2000
3 PLEURISY BACTERIAL 6 0.1463
4 BLADDER DYSPLASIA 2 0.1111
5 URINARY BLADDER HAEMATOMA 3 0.1111
6 URINARY BLADDER ATROPHY 4 0.0870
7 IMMUNE-MEDIATED ADVERSE REACTION 126 0.0820
8 TOXIC ERYTHEMA OF CHEMOTHERAPY 20 0.0772
9 KL-6 INCREASED 17 0.0752
10 UROSTOMY COMPLICATION 3 0.0625
11 INFUSION SITE EXFOLIATION 3 0.0577
12 IMMUNOTOXICITY 6 0.0526
13 BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT 4 0.0392
14 IMMUNE-MEDIATED NEPHRITIS 17 0.0362
15 MALIGNANT GASTROINTESTINAL OBSTRUCTION 3 0.0357
16 IMMUNE-MEDIATED NEUROLOGICAL DISORDER 3 0.0345
17 ANTISYNTHETASE SYNDROME 5 0.0278
18 PARALYSIS RECURRENT LARYNGEAL NERVE 4 0.0274
19 BLOOD LACTIC ACID ABNORMAL 3 0.0268
20 THROMBOPHLEBITIS MIGRANS 9 0.0265
21 IMMUNE-MEDIATED NEUROPATHY 4 0.0258
22 IMMUNE-MEDIATED MYASTHENIA GRAVIS 8 0.0246
23 TUMOUR ASSOCIATED FEVER 10 0.0244
24 SUPERFICIAL INFLAMMATORY DERMATOSIS 3 0.0244
25 TUMOUR HYPERPROGRESSION 6 0.0242
26 IMMUNE-MEDIATED RENAL DISORDER 10 0.0242
27 IMMUNE-MEDIATED LUNG DISEASE 43 0.0236
28 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 19 0.0231
29 METASTATIC CARCINOMA OF THE BLADDER 8 0.0226
30 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 18 0.0226
31 HYPERCALCAEMIA OF MALIGNANCY 6 0.0221
32 SJS-TEN OVERLAP 15 0.0214
33 TRANSITIONAL CELL CARCINOMA 27 0.0208
34 LEUKODERMA 4 0.0201
35 SKIN TOXICITY 110 0.0194
36 BACTERIAL TRANSLOCATION 6 0.0189
37 BLADDER PERFORATION 7 0.0181
38 IMMUNE-MEDIATED ENTEROCOLITIS 66 0.0179
39 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 22 0.0177
40 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 4 0.0175
41 IMMUNE-MEDIATED CHOLANGITIS 6 0.0167
42 INFECTIVE SPONDYLITIS 4 0.0166
43 INFUSION SITE NECROSIS 3 0.0156
44 SICCA SYNDROME 3 0.0155
45 SEPTIC PULMONARY EMBOLISM 3 0.0154
46 MALIGNANT NEOPLASM OLIGOPROGRESSION 3 0.0151
47 VASCULAR ACCESS COMPLICATION 12 0.0148
48 CUTANEOUS SYMPTOM 10 0.0146
49 MORAXELLA INFECTION 4 0.0146
50 OCULAR TOXICITY 16 0.0145
51 IMMUNE-MEDIATED MYOCARDITIS 22 0.0136
52 PERIPHERAL MOTOR NEUROPATHY 19 0.0136
53 EPIDERMAL NECROSIS 13 0.0133
54 IMMUNE-MEDIATED ENCEPHALITIS 7 0.0132
55 BLADDER TAMPONADE 4 0.0132
56 TASTE DISORDER 265 0.0130
57 BLOOD INSULIN DECREASED 2 0.0129
58 IMMUNE-MEDIATED HEPATIC DISORDER 25 0.0128
59 SEVERE CUTANEOUS ADVERSE REACTION 3 0.0126
60 DERMATITIS BULLOUS 88 0.0121
61 CAMPYLOBACTER INFECTION 10 0.0120
62 PULMONARY TOXICITY 85 0.0120
63 URINARY BLADDER RUPTURE 3 0.0118
64 TOXIC EPIDERMAL NECROLYSIS 170 0.0112
65 ADMINISTRATION SITE EXTRAVASATION 11 0.0110
66 EPIDERMOLYSIS 5 0.0109
67 MECHANICAL ILEUS 6 0.0105
68 IMMUNE-MEDIATED PANCREATITIS 4 0.0105
69 DILATATION INTRAHEPATIC DUCT ACQUIRED 3 0.0103
70 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 9 0.0103
71 TISSUE INFILTRATION 3 0.0102
72 CATHETER SITE EXTRAVASATION 4 0.0100
73 DUODENAL OBSTRUCTION 3 0.0100
74 STEVENS-JOHNSON SYNDROME 222 0.0100
75 CANCER PAIN 25 0.0098
76 NEUROPATHY PERIPHERAL 909 0.0095
77 INFUSION SITE VESICLES 5 0.0095
78 ADULT FAILURE TO THRIVE 2 0.0094
79 SKIN DISORDER 314 0.0094
80 THERAPY PARTIAL RESPONDER 144 0.0092
81 CREATINE KINASE INCREASED 7 0.0091
82 BLADDER CANCER RECURRENT 9 0.0090
83 IMMUNE-MEDIATED DERMATITIS 9 0.0089
84 DISTAL INTESTINAL OBSTRUCTION SYNDROME 3 0.0089
85 VASCULAR DEVICE OCCLUSION 3 0.0088
86 IMMUNE-MEDIATED HEPATITIS 18 0.0088
87 MALIGNANT NEOPLASM PROGRESSION 893 0.0087
88 XEROPHTHALMIA 5 0.0085
89 BIOPSY SKIN ABNORMAL 2 0.0083
90 TUMOUR PSEUDOPROGRESSION 9 0.0082
91 STOMAL HERNIA 3 0.0082
92 NEPHRITIS 27 0.0081
93 HYPERGLYCAEMIA 276 0.0076
94 LICHENOID KERATOSIS 17 0.0074
95 GENITAL ABSCESS 3 0.0074
96 ANHIDROSIS 3 0.0074
97 INTERTRIGO 4 0.0073
98 IMMUNE-MEDIATED MYOSITIS 20 0.0072
99 INFUSION SITE EXTRAVASATION 44 0.0071
100 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 10 0.0070
101 HYDRONEPHROSIS 51 0.0068
102 IMMUNE-MEDIATED HYPOPHYSITIS 3 0.0067
103 ENTEROCOLITIS 38 0.0066
104 SKIN EROSION 21 0.0065
105 PERIPHERAL SENSORY NEUROPATHY 38 0.0065
106 LUNG OPACITY 17 0.0064
107 MUSCLE ABSCESS 4 0.0064
108 PERIPHERAL SENSORIMOTOR NEUROPATHY 8 0.0064
109 PHYSICAL DECONDITIONING 16 0.0062
110 ABDOMINAL WALL ABSCESS 4 0.0062
111 BLOOD CORTICOTROPHIN DECREASED 3 0.0061
112 IMMUNE-MEDIATED THYROIDITIS 3 0.0061
113 DERMATITIS INFECTED 3 0.0060
114 URETERIC OBSTRUCTION 8 0.0059
115 INSULIN RESISTANCE 12 0.0058
116 ONYCHOLYSIS 9 0.0058
117 INFUSION SITE CELLULITIS 3 0.0057
118 ADRENAL INSUFFICIENCY 69 0.0057
119 FAECAL VOMITING 3 0.0056
120 RECTAL PERFORATION 3 0.0056
121 BLOOD MAGNESIUM ABNORMAL 3 0.0054
122 BILIARY OBSTRUCTION 7 0.0054
123 POSTOPERATIVE ILEUS 3 0.0053
124 SKIN REACTION 75 0.0053
125 ENANTHEMA 3 0.0052
126 CYTOMEGALOVIRUS ENTEROCOLITIS 4 0.0052
127 DERMATITIS EXFOLIATIVE GENERALISED 18 0.0052
128 HYPOGEUSIA 10 0.0051
129 DIABETIC METABOLIC DECOMPENSATION 7 0.0050
130 CHOLANGITIS 31 0.0050
131 URINARY TRACT INFECTION PSEUDOMONAL 3 0.0050
132 EXFOLIATIVE RASH 13 0.0049
133 DEMYELINATING POLYNEUROPATHY 5 0.0049
134 PSOAS ABSCESS 3 0.0048
135 METASTASES TO PELVIS 3 0.0047
136 PYELONEPHRITIS 41 0.0047
137 MYOCARDITIS 54 0.0047
138 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
139 HEPATIC HAEMORRHAGE 4 0.0047
140 AUTOIMMUNE COLITIS 3 0.0047
141 URINARY TRACT OBSTRUCTION 11 0.0046
142 DRUG ERUPTION 80 0.0045
143 HEAT ILLNESS 3 0.0044
144 INTERSTITIAL LUNG DISEASE 214 0.0044
145 EXTRAVASATION 18 0.0044
146 PIGMENTATION DISORDER 27 0.0044
147 RASH VESICULAR 21 0.0043
148 ERYTHEMA MULTIFORME 40 0.0043
149 AUTOIMMUNE MYOSITIS 2 0.0042
150 METASTASES TO LUNG 49 0.0042
151 GUILLAIN-BARRE SYNDROME 20 0.0041
152 PNEUMONITIS 112 0.0041
153 MYELOSUPPRESSION 147 0.0041
154 PYELONEPHRITIS ACUTE 8 0.0041
155 DUODENAL PERFORATION 4 0.0041
156 MUCOSAL DISORDER 4 0.0040
157 METASTASES TO LYMPH NODES 27 0.0040
158 ENTEROVESICAL FISTULA 3 0.0040
159 ILEUS 49 0.0039
160 GENITAL ULCERATION 3 0.0039
161 URINARY BLADDER HAEMORRHAGE 8 0.0038
162 BLOOD SODIUM ABNORMAL 4 0.0038
163 HEPATIC FUNCTION ABNORMAL 140 0.0037
164 LYMPHANGITIS 3 0.0037
165 PEMPHIGOID 28 0.0037
166 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
167 METASTASES TO LIVER 63 0.0036
168 MYOCARDIAL NECROSIS MARKER INCREASED 6 0.0036
169 IMMUNE-MEDIATED HYPOTHYROIDISM 4 0.0035
170 BLOOD PRESSURE DIASTOLIC DECREASED 26 0.0035
171 CACHEXIA 18 0.0035
172 MYOSITIS 31 0.0035
173 TYPE 1 DIABETES MELLITUS 20 0.0033
174 RASH MACULO-PAPULAR 73 0.0033
175 METASTASES TO ADRENALS 3 0.0033
176 MYASTHENIA GRAVIS 26 0.0032
177 URINARY TRACT INFECTION ENTEROCOCCAL 3 0.0032
178 PERFORMANCE STATUS DECREASED 15 0.0032
179 METASTASES TO PERITONEUM 8 0.0032
180 HAEMORRHAGE URINARY TRACT 8 0.0031
181 RADIOTHERAPY 6 0.0031
182 BACTERIAL SEPSIS 10 0.0031
183 INTERCEPTED PRODUCT PRESCRIBING ERROR 4 0.0030
184 AMYLASE INCREASED 11 0.0030
185 DIABETIC KETOACIDOSIS 71 0.0030
186 FULMINANT TYPE 1 DIABETES MELLITUS 3 0.0029
187 METASTASES TO SKIN 3 0.0029
188 COLITIS 108 0.0028
189 TUMOUR LYSIS SYNDROME 25 0.0028
190 CYTOKINE RELEASE SYNDROME 57 0.0028
191 TUMOUR NECROSIS 3 0.0028
192 POLYNEUROPATHY 34 0.0028
193 PRERENAL FAILURE 4 0.0028
194 ENTEROCOCCAL BACTERAEMIA 3 0.0028
195 HEPATIC CYTOLYSIS 36 0.0028
196 POST HERPETIC NEURALGIA 4 0.0028
197 MIXED LIVER INJURY 8 0.0027
198 SECONDARY ADRENOCORTICAL INSUFFICIENCY 4 0.0026
199 METASTASES TO MENINGES 6 0.0026
200 CORTISOL DECREASED 3 0.0026
201 BLOOD PRESSURE SYSTOLIC INCREASED 51 0.0026
202 PELVIC ABSCESS 3 0.0026
203 ORAL MUCOSAL ERUPTION 4 0.0026
204 HEPATITIS 65 0.0025
205 METASTASES TO BONE 41 0.0025
206 DERMATITIS PSORIASIFORM 5 0.0024
207 SKIN HYPERPIGMENTATION 21 0.0024
208 XEROSIS 3 0.0024
209 METASTASES TO CENTRAL NERVOUS SYSTEM 31 0.0024
210 SKIN WOUND 4 0.0024
211 INFUSION SITE REACTION 7 0.0023
212 RASH 1019 0.0023
213 INFUSION SITE IRRITATION 3 0.0023
214 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66 0.0023
215 DACRYOSTENOSIS ACQUIRED 3 0.0023
216 KERATITIS 7 0.0023
217 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
218 HYPOPITUITARISM 4 0.0023
219 AXONAL NEUROPATHY 2 0.0023
220 PNEUMOCYSTIS JIROVECII PNEUMONIA 23 0.0023
221 NEUTROPHIL COUNT DECREASED 93 0.0023
222 BLISTER 128 0.0023
223 APPETITE DISORDER 15 0.0023
224 INTESTINAL DILATATION 3 0.0022
225 INFUSION SITE RASH 3 0.0022
226 TOXIC SKIN ERUPTION 22 0.0022
227 HYPOPHOSPHATAEMIA 16 0.0022
228 AUTOIMMUNE HEPATITIS 15 0.0022
229 ADRENAL DISORDER 4 0.0021
230 MUCOSAL INFLAMMATION 54 0.0021
231 UROSEPSIS 19 0.0021
232 GASTROINTESTINAL WALL THICKENING 3 0.0020
233 THYROIDITIS 6 0.0020
234 PROSTATITIS 6 0.0020
235 CYTOPENIA 24 0.0020
236 LACRIMATION INCREASED 59 0.0020
237 CHOLANGITIS SCLEROSING 4 0.0019
238 DRY EYE 97 0.0019
239 POOR VENOUS ACCESS 20 0.0019
240 AGEUSIA 48 0.0019
241 FEBRILE NEUTROPENIA 127 0.0019
242 OSTEOSCLEROSIS 3 0.0019
243 HYPERPYREXIA 8 0.0019
244 COMPRESSION FRACTURE 10 0.0019
245 HYPERPHOSPHATAEMIA 4 0.0019
246 PNEUMONIA BACTERIAL 17 0.0019
247 ORAL FUNGAL INFECTION 5 0.0018
248 DECREASED APPETITE 424 0.0018
249 CORNEAL DISORDER 4 0.0018
250 LIMB MASS 4 0.0018
251 RASH MORBILLIFORM 5 0.0018
252 DERMATITIS EXFOLIATIVE 9 0.0018
253 PSEUDOMEMBRANOUS COLITIS 4 0.0018
254 MALIGNANT PLEURAL EFFUSION 3 0.0018
255 NEOPLASM RECURRENCE 6 0.0018
256 BLOOD LOSS ANAEMIA 4 0.0018
257 OBSTRUCTION 7 0.0018
258 TUMOUR HAEMORRHAGE 5 0.0018
259 BLEPHARITIS 7 0.0017
260 RASH PRURITIC 94 0.0017
261 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 13 0.0017
262 HYPERTRANSAMINASAEMIA 12 0.0017
263 LICHEN PLANUS 4 0.0017
264 HAEMATURIA 59 0.0017
265 HYPOTHYROIDISM 55 0.0017
266 TROPONIN INCREASED 13 0.0017
267 PAPULE 12 0.0017
268 ACIDOSIS 13 0.0017
269 SKIN ABRASION 8 0.0017
270 DEVICE RELATED INFECTION 26 0.0017
271 PUSTULE 4 0.0017
272 BACTERAEMIA 20 0.0017
273 BILE DUCT CANCER 2 0.0017
274 GASTROINTESTINAL MOTILITY DISORDER 9 0.0017
275 VOCAL CORD PARALYSIS 3 0.0017
276 ATYPICAL PNEUMONIA 5 0.0017
277 WEIGHT ABNORMAL 4 0.0017
278 INFUSION SITE ERYTHEMA 14 0.0017
279 HYPOMAGNESAEMIA 23 0.0017
280 ALOPECIA 324 0.0016
281 ELECTROLYTE IMBALANCE 19 0.0016
282 PNEUMOPERITONEUM 3 0.0016
283 BLADDER DISCOMFORT 2 0.0016
284 PNEUMONIA ASPIRATION 40 0.0016
285 TUBULOINTERSTITIAL NEPHRITIS 30 0.0016
286 SMALL INTESTINAL PERFORATION 3 0.0016
287 INTERVERTEBRAL DISCITIS 3 0.0016
288 LARGE INTESTINE PERFORATION 11 0.0016
289 PATHOLOGICAL FRACTURE 8 0.0016
290 BLADDER PAIN 5 0.0016
291 SECOND PRIMARY MALIGNANCY 13 0.0016
292 BLOOD BILIRUBIN ABNORMAL 2 0.0016
293 HEPATIC MASS 3 0.0016
294 SUSPECTED OFF LABEL USE 7 0.0015
295 RASH ERYTHEMATOUS 74 0.0015
296 LIVER ABSCESS 5 0.0015
297 HYPERCALCAEMIA 19 0.0015
298 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
299 HEPATOTOXICITY 34 0.0015
300 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
301 PNEUMONIA FUNGAL 6 0.0015
302 LIVER DISORDER 67 0.0015
303 SKIN INJURY 5 0.0015
304 BLOOD POTASSIUM ABNORMAL 4 0.0015
305 BLOOD PRESSURE FLUCTUATION 36 0.0015
306 HYPOPHYSITIS 3 0.0015
307 RENAL HAEMORRHAGE 3 0.0015
308 INJECTION SITE NECROSIS 3 0.0015
309 DECUBITUS ULCER 12 0.0015
310 KETOACIDOSIS 11 0.0015
311 HYPERURICAEMIA 6 0.0015
312 VENOUS THROMBOSIS LIMB 3 0.0015
313 CAPILLARY LEAK SYNDROME 3 0.0014
314 ENCEPHALITIS 10 0.0014
315 MACULE 4 0.0014
316 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
317 STAPHYLOCOCCAL SEPSIS 7 0.0014
318 DUODENAL ULCER 10 0.0014
319 FEBRILE BONE MARROW APLASIA 6 0.0014
320 CHOLESTASIS 27 0.0014
321 LIVER FUNCTION TEST INCREASED 30 0.0014
322 BLADDER TRANSITIONAL CELL CARCINOMA 2 0.0014
323 INFUSION SITE BRUISING 3 0.0014
324 DERMATITIS 29 0.0014
325 DRY MOUTH 111 0.0014
326 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
327 ILEUS PARALYTIC 6 0.0013
328 NEUTROPENIA 181 0.0013
329 GENERAL PHYSICAL CONDITION ABNORMAL 9 0.0013
330 PNEUMOTHORAX 21 0.0013
331 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
332 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
333 HYPERTHYROIDISM 19 0.0013
334 RENAL IMPAIRMENT 110 0.0013
335 DRUG-INDUCED LIVER INJURY 41 0.0013
336 CYTOMEGALOVIRUS COLITIS 3 0.0013
337 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
338 ESCHERICHIA BACTERAEMIA 3 0.0013
339 BLOOD MAGNESIUM DECREASED 11 0.0013
340 INFUSION SITE SWELLING 8 0.0013
341 METASTASIS 9 0.0013
342 NEUROTOXICITY 22 0.0013
343 WEIGHT FLUCTUATION 13 0.0012
344 ORGAN FAILURE 5 0.0012
345 PANNICULITIS 3 0.0012
346 C-REACTIVE PROTEIN INCREASED 45 0.0012
347 SKIN EXFOLIATION 104 0.0012
348 HAEMATOLOGICAL INFECTION 3 0.0012
349 SHOCK 28 0.0012
350 PRURITUS 467 0.0012
351 GASTROINTESTINAL PERFORATION 5 0.0012
352 BLADDER CANCER STAGE IV 2 0.0012
353 SYSTEMIC CANDIDA 3 0.0012
354 ERYSIPELAS 6 0.0012
355 PLATELET DISORDER 3 0.0012
356 ASPIRATION 13 0.0012
357 URINARY TRACT INFECTION BACTERIAL 3 0.0012
358 INTESTINAL STENOSIS 5 0.0012
359 DERMATOMYOSITIS 3 0.0012
360 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
361 INCREASED BRONCHIAL SECRETION 3 0.0012
362 BLADDER NEOPLASM 2 0.0012
363 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
364 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 27 0.0012
365 BLOOD CHLORIDE INCREASED 2 0.0012
366 BLOOD CREATININE ABNORMAL 4 0.0012
367 SKIN DISCOLOURATION 53 0.0012
368 CEREBRAL INFARCTION 28 0.0011
369 DYSGEUSIA 85 0.0011
370 BLOOD LACTIC ACID INCREASED 6 0.0011
371 RADICULOPATHY 3 0.0011
372 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
373 SUDDEN DEATH 12 0.0011
374 CONJUNCTIVITIS 21 0.0011
375 SEPTIC SHOCK 49 0.0011
376 CONJUNCTIVAL HYPERAEMIA 4 0.0011
377 SKIN WEEPING 4 0.0011
378 INTERCEPTED PRODUCT STORAGE ERROR 4 0.0011
379 ACUTE KIDNEY INJURY 170 0.0011
380 HYPOCALCAEMIA 21 0.0011
381 VASCULAR DEVICE INFECTION 5 0.0011
382 UNDERDOSE 80 0.0011
383 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 196 0.0011
384 RASH PAPULAR 24 0.0011
385 INTESTINAL PERFORATION 12 0.0011
386 FLANK PAIN 10 0.0011
387 RENAL TUBULAR DISORDER 3 0.0011
388 PERONEAL NERVE PALSY 6 0.0011
389 HAEMATOTOXICITY 10 0.0011
390 OESOPHAGEAL ULCER 4 0.0010
391 DYSPNOEA AT REST 3 0.0010
392 FEEDING DISORDER 21 0.0010
393 TRANSAMINASES INCREASED 23 0.0010
394 DERMATITIS ALLERGIC 13 0.0010
395 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
396 HYPONATRAEMIA 58 0.0010
397 GASTROINTESTINAL NECROSIS 3 0.0010
398 HYPOALBUMINAEMIA 8 0.0010
399 HYPOAESTHESIA 154 0.0010
400 PANCREATITIS ACUTE 23 0.0010
401 AGRANULOCYTOSIS 19 0.0010
402 BICYTOPENIA 2 0.0010
403 SEPSIS 113 0.0010
404 HEPATITIS FULMINANT 3 0.0010
405 DIABETIC NEUROPATHY 5 0.0010
406 OESOPHAGEAL CANDIDIASIS 4 0.0010
407 FUNGAL SKIN INFECTION 4 0.0010
408 STOMATITIS 60 0.0010
409 KLEBSIELLA INFECTION 5 0.0010
410 DRY SKIN 131 0.0010
411 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
412 HEART RATE DECREASED 34 0.0010
413 HYPERBILIRUBINAEMIA 10 0.0010
414 PERIORBITAL OEDEMA 5 0.0010
415 DISEASE PROGRESSION 113 0.0010
416 BILE DUCT STONE 3 0.0009
417 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
418 GENERAL PHYSICAL HEALTH DETERIORATION 109 0.0009
419 CHOLECYSTITIS 11 0.0009
420 OEDEMA 50 0.0009
421 SKIN LESION 25 0.0009
422 WALKING AID USER 6 0.0009
423 DIABETES MELLITUS 69 0.0009
424 PYREXIA 313 0.0009
425 INTESTINAL OBSTRUCTION 34 0.0009
426 BLOOD SODIUM DECREASED 17 0.0009
427 MENINGITIS 6 0.0009
428 TONGUE ULCERATION 3 0.0009
429 CLOSTRIDIAL INFECTION 3 0.0009
430 LEUKOPENIA 44 0.0009
431 ERYTHEMA 180 0.0009
432 BLOOD DISORDER 7 0.0009
433 LUMBAR VERTEBRAL FRACTURE 4 0.0009
434 SKIN ATROPHY 5 0.0009
435 EYE DISCHARGE 9 0.0009
436 ASPARTATE AMINOTRANSFERASE INCREASED 46 0.0009
437 LOCALISED OEDEMA 4 0.0009
438 NEOPLASM PROGRESSION 30 0.0009
439 RENAL FUNCTION TEST ABNORMAL 4 0.0009
440 ANAEMIA 164 0.0009
441 EAR PRURITUS 3 0.0009
442 SKIN TIGHTNESS 4 0.0008
443 FIBRIN D DIMER INCREASED 3 0.0008
444 GASTRIC ULCER 16 0.0008
445 EOSINOPHIL COUNT INCREASED 7 0.0008
446 ORAL CANDIDIASIS 11 0.0008
447 HYPOVOLAEMIC SHOCK 4 0.0008
448 PANCREATITIS 44 0.0008
449 BONE LESION 3 0.0008
450 BLOOD PHOSPHORUS DECREASED 3 0.0008
451 SENSITIVE SKIN 6 0.0008
452 SMALL INTESTINAL OBSTRUCTION 10 0.0008
453 INJECTION SITE EXTRAVASATION 10 0.0008
454 CARDIAC DYSFUNCTION 3 0.0008
455 URINARY TRACT INFECTION 136 0.0008
456 HEPATIC NECROSIS 3 0.0008
457 THROMBOCYTOPENIA 89 0.0008
458 CATHETER SITE INFECTION 3 0.0008
459 ABDOMINAL INFECTION 2 0.0008
460 HYPOPHAGIA 20 0.0008
461 ENTERITIS 5 0.0008
462 PHLEBITIS 4 0.0008
463 DIARRHOEA 503 0.0008
464 AORTIC ARTERIOSCLEROSIS 2 0.0008
465 INFUSION SITE PAIN 10 0.0008
466 MUSCLE RUPTURE 3 0.0008
467 WEIGHT DECREASED 215 0.0008
468 WOUND SECRETION 3 0.0008
469 BRAIN FOG 12 0.0008
470 POLYARTHRITIS 4 0.0008
471 CORONAVIRUS INFECTION 5 0.0008
472 SKIN PAPILLOMA 3 0.0007
473 EOSINOPHILIA 13 0.0007
474 LEUKAEMIA 7 0.0007
475 DEHYDRATION 98 0.0007
476 HEPATIC ENZYME INCREASED 50 0.0007
477 OESOPHAGITIS 8 0.0007
478 HEPATIC FAILURE 22 0.0007
479 THIRST 13 0.0007
480 AORTIC DISSECTION 3 0.0007
481 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
482 DELIRIUM 25 0.0007
483 AUTOIMMUNE DISORDER 7 0.0007
484 MALNUTRITION 8 0.0007
485 RASH MACULAR 25 0.0007
486 ONYCHOMADESIS 3 0.0007
487 ASCITES 21 0.0007
488 RIGHT VENTRICULAR FAILURE 5 0.0007
489 CANDIDA INFECTION 12 0.0007
490 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
491 BLOOD CREATININE INCREASED 46 0.0007
492 BLOOD BILIRUBIN INCREASED 19 0.0007
493 LUNG NEOPLASM 3 0.0007
494 PULMONARY TUBERCULOSIS 3 0.0007
495 SKIN ULCER 18 0.0007
496 BLOOD URIC ACID INCREASED 4 0.0007
497 ECZEMA 36 0.0007
498 STRESS CARDIOMYOPATHY 4 0.0007
499 IMMOBILE 3 0.0007
500 MOTOR DYSFUNCTION 7 0.0007
501 ALANINE AMINOTRANSFERASE INCREASED 42 0.0007
502 HYPOVOLAEMIA 4 0.0007
503 ORAL DISORDER 5 0.0007
504 MELAENA 15 0.0007
505 PANCYTOPENIA 38 0.0007
506 LUNG INFILTRATION 6 0.0007
507 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
508 BLOOD CREATINE INCREASED 3 0.0007
509 WHEELCHAIR USER 3 0.0007
510 JAUNDICE 18 0.0007
511 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
512 PRODUCT USE ISSUE 124 0.0007
513 INGUINAL HERNIA 4 0.0007
514 OEDEMA PERIPHERAL 80 0.0007
515 DISEASE COMPLICATION 3 0.0007
516 RETINAL DETACHMENT 6 0.0007
517 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
518 CONSTIPATION 142 0.0007
519 INTERCEPTED PRODUCT PREPARATION ERROR 8 0.0006
520 LYMPHADENOPATHY 23 0.0006
521 OLIGURIA 4 0.0006
522 NASAL DRYNESS 4 0.0006
523 SWELLING OF EYELID 4 0.0006
524 CARDIAC FAILURE 51 0.0006
525 MUSCLE ATROPHY 8 0.0006
526 GINGIVAL PAIN 5 0.0006
527 SUBCUTANEOUS ABSCESS 3 0.0006
528 METABOLIC ACIDOSIS 20 0.0006
529 OXYGEN SATURATION DECREASED 35 0.0006
530 HEPATITIS ACUTE 4 0.0006
531 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
532 ASTHENIA 231 0.0006
533 SHOCK HAEMORRHAGIC 5 0.0006
534 ABNORMAL FAECES 5 0.0006
535 HICCUPS 5 0.0006
536 ORGANISING PNEUMONIA 3 0.0006
537 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
538 PROTEIN URINE PRESENT 3 0.0006
539 HEPATIC ENZYME ABNORMAL 3 0.0006
540 TOXIC ENCEPHALOPATHY 3 0.0006
541 MOVEMENT DISORDER 19 0.0006
542 HYPOKALAEMIA 27 0.0006
543 ENDOCARDITIS 3 0.0006
544 NEPHROTIC SYNDROME 4 0.0006
545 BLOOD URINE PRESENT 11 0.0006
546 SKIN NECROSIS 3 0.0006
547 INFUSION RELATED REACTION 38 0.0006
548 NAIL DISORDER 5 0.0006
549 ENCEPHALOPATHY 14 0.0006
550 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
551 INCONTINENCE 6 0.0006
552 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
553 DIALYSIS 8 0.0006
554 THERMAL BURN 4 0.0006
555 NEUTROPENIC SEPSIS 4 0.0006
556 PEMPHIGUS 7 0.0006
557 ANAL FISSURE 3 0.0006
558 PARALYSIS 8 0.0006
559 PLEURAL EFFUSION 34 0.0006
560 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
561 SKIN LACERATION 6 0.0006
562 LUNG DISORDER 27 0.0006
563 FAECES SOFT 4 0.0005
564 RASH PUSTULAR 4 0.0005
565 HYPERKERATOSIS 3 0.0005
566 FATIGUE 423 0.0005
567 BLOOD PRESSURE DECREASED 36 0.0005
568 GASTRIC ULCER HAEMORRHAGE 3 0.0005
569 CATARACT 32 0.0005
570 DYSPHAGIA 51 0.0005
571 PULMONARY MASS 8 0.0005
572 RENAL DISORDER 25 0.0005
573 CELLULITIS 27 0.0005
574 COGNITIVE DISORDER 25 0.0005
575 ANGIOPATHY 3 0.0005
576 RESPIRATORY FAILURE 39 0.0005
577 NEURALGIA 13 0.0005
578 ACUTE PULMONARY OEDEMA 3 0.0005
579 OCULAR DISCOMFORT 6 0.0005
580 DYSPNOEA EXERTIONAL 20 0.0005
581 CHOLECYSTITIS ACUTE 3 0.0005
582 AUTOIMMUNE THYROIDITIS 2 0.0005
583 FRACTURE 10 0.0005
584 RENAL FAILURE 70 0.0005
585 SCAB 6 0.0005
586 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
587 LIPASE INCREASED 4 0.0005
588 METABOLIC DISORDER 3 0.0005
589 SKIN WARM 3 0.0005
590 ABDOMINAL PAIN LOWER 13 0.0005
591 HYPERKALAEMIA 18 0.0005
592 BODY TEMPERATURE DECREASED 5 0.0005
593 DEATH 436 0.0005
594 SYMPTOM RECURRENCE 3 0.0005
595 PRESCRIBED UNDERDOSE 10 0.0005
596 HEPATITIS CHOLESTATIC 3 0.0005
597 SENSORY LOSS 4 0.0005
598 STENT PLACEMENT 4 0.0005
599 INJECTION SITE VESICLES 3 0.0005
600 NOCTURIA 6 0.0005
601 BONE MARROW FAILURE 10 0.0005
602 EYELID PTOSIS 5 0.0005
603 MALAISE 214 0.0005
604 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
605 HYPERAESTHESIA 4 0.0005
606 LARYNGEAL OEDEMA 3 0.0005
607 VENTRICULAR TACHYCARDIA 8 0.0005
608 MYELODYSPLASTIC SYNDROME 7 0.0005
609 ACUTE CORONARY SYNDROME 4 0.0005
610 HEMIPLEGIA 4 0.0005
611 SKIN PLAQUE 4 0.0005
612 SCRATCH 5 0.0005
613 PROTEINURIA 9 0.0005
614 PARAESTHESIA 74 0.0005
615 ACUTE RESPIRATORY FAILURE 9 0.0005
616 HAEMOGLOBIN ABNORMAL 3 0.0005
617 ABNORMAL SENSATION IN EYE 2 0.0005
618 PRESCRIBED OVERDOSE 9 0.0005
619 WHITE BLOOD CELL COUNT DECREASED 50 0.0005
620 INFECTION 66 0.0005
621 THYROID DISORDER 7 0.0005
622 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
623 LYMPHOCYTE COUNT DECREASED 8 0.0005
624 ABDOMINAL ABSCESS 2 0.0005
625 GAIT INABILITY 15 0.0004
626 TERMINAL STATE 3 0.0004
627 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
628 QUALITY OF LIFE DECREASED 6 0.0004
629 ORAL PAIN 10 0.0004
630 BLOOD CALCIUM DECREASED 5 0.0004
631 WRONG PRODUCT ADMINISTERED 3 0.0004
632 LEUKOCYTOSIS 8 0.0004
633 CYSTITIS 14 0.0004
634 ONYCHOCLASIS 3 0.0004
635 LYMPHOEDEMA 3 0.0004
636 BLOOD GLUCOSE ABNORMAL 8 0.0004
637 HEPATIC STEATOSIS 8 0.0004
638 DEFAECATION URGENCY 3 0.0004
639 BLOOD TEST ABNORMAL 6 0.0004
640 DEVICE OCCLUSION 6 0.0004
641 HYPOXIA 15 0.0004
642 STAPHYLOCOCCAL INFECTION 14 0.0004
643 COVID-19 PNEUMONIA 5 0.0004
644 CONDITION AGGRAVATED 128 0.0004
645 DEAFNESS 11 0.0004
646 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
647 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
648 FACE OEDEMA 7 0.0004
649 SKIN IRRITATION 19 0.0004
650 OFF LABEL USE 362 0.0004
651 INTENTIONAL UNDERDOSE 3 0.0004
652 HAEMOGLOBIN DECREASED 42 0.0004
653 BLOOD GLUCOSE INCREASED 77 0.0004
654 RENAL TUBULAR NECROSIS 4 0.0004
655 DYSURIA 15 0.0004
656 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
657 THERAPY CHANGE 4 0.0004
658 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
659 GENERALISED OEDEMA 5 0.0004
660 PLATELET COUNT DECREASED 43 0.0004
661 BLADDER DISORDER 4 0.0004
662 BLOOD PRESSURE ABNORMAL 8 0.0004
663 PULMONARY OEDEMA 18 0.0004
664 PULMONARY EMBOLISM 38 0.0004
665 RESPIRATORY DISTRESS 11 0.0004
666 POISONING 5 0.0004
667 FULL BLOOD COUNT DECREASED 8 0.0004
668 DRY THROAT 4 0.0004
669 HYPERTHERMIA 3 0.0004
670 URINARY RETENTION 13 0.0004
671 APHTHOUS ULCER 3 0.0004
672 OSTEOMYELITIS 7 0.0004
673 PELVIC PAIN 7 0.0004
674 ACUTE MYELOID LEUKAEMIA 6 0.0004
675 HERPES ZOSTER 22 0.0004
676 PRODUCTIVE COUGH 18 0.0004
677 BLADDER CANCER 22 0.0004
678 VISION BLURRED 51 0.0004
679 PAIN OF SKIN 10 0.0004
680 MUSCLE DISORDER 3 0.0004
681 BLOOD POTASSIUM INCREASED 6 0.0004
682 UVEITIS 5 0.0004
683 LIVER INJURY 9 0.0004
684 NAUSEA 290 0.0004
685 ASTHENOPIA 2 0.0004
686 PNEUMONIA 117 0.0004
687 SENSATION OF FOREIGN BODY 3 0.0004
688 VOMITING 167 0.0004
689 TOXICITY TO VARIOUS AGENTS 59 0.0003
690 PSEUDOMONAS INFECTION 3 0.0003
691 ANURIA 3 0.0003
692 MYOPATHY 3 0.0003
693 URINE OUTPUT DECREASED 3 0.0003
694 MUSCULAR WEAKNESS 39 0.0003
695 BURNING SENSATION 24 0.0003
696 BLOOD CALCIUM INCREASED 3 0.0003
697 DYSPHONIA 20 0.0003
698 GROIN PAIN 3 0.0003
699 ACUTE MYOCARDIAL INFARCTION 10 0.0003
700 PURPURA 3 0.0003
701 DEEP VEIN THROMBOSIS 22 0.0003
702 CARDIOMYOPATHY 5 0.0003
703 POLLAKIURIA 14 0.0003
704 EYE DISORDER 11 0.0003
705 HYPOTENSION 67 0.0003
706 BLOOD POTASSIUM DECREASED 10 0.0003
707 FUNGAL INFECTION 11 0.0003
708 HEART RATE INCREASED 32 0.0003
709 HAEMOPTYSIS 9 0.0003
710 APPENDICITIS 3 0.0003
711 DIARRHOEA HAEMORRHAGIC 3 0.0003
712 ATRIAL FIBRILLATION 31 0.0003
713 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
714 HAEMATEMESIS 8 0.0003
715 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
716 ULCER 5 0.0003
717 SCIATICA 5 0.0003
718 ABSCESS 5 0.0003
719 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
720 ATELECTASIS 3 0.0003
721 DIZZINESS POSTURAL 3 0.0003
722 COVID-19 54 0.0003
723 BACK PAIN 70 0.0003
724 EYE HAEMORRHAGE 4 0.0003
725 TYPE 2 DIABETES MELLITUS 10 0.0003
726 OCULAR HYPERAEMIA 14 0.0003
727 SUBARACHNOID HAEMORRHAGE 3 0.0003
728 BODY TEMPERATURE INCREASED 6 0.0003
729 ABNORMAL LOSS OF WEIGHT 2 0.0003
730 TEMPERATURE INTOLERANCE 3 0.0003
731 INFLAMMATION 15 0.0003
732 NERVOUS SYSTEM DISORDER 9 0.0003
733 TENDERNESS 3 0.0003
734 BLOOD PRESSURE INCREASED 44 0.0003
735 ORTHOSTATIC HYPOTENSION 5 0.0003
736 CARDIO-RESPIRATORY ARREST 12 0.0003
737 MASS 4 0.0003
738 MOUTH ULCERATION 6 0.0003
739 FULL BLOOD COUNT ABNORMAL 3 0.0003
740 BLINDNESS UNILATERAL 4 0.0003
741 LYMPHOPENIA 4 0.0003
742 SEASONAL ALLERGY 4 0.0003
743 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
744 LIVER FUNCTION TEST ABNORMAL 8 0.0003
745 GASTROENTERITIS 4 0.0003
746 THROMBOSIS 22 0.0003
747 GASTROINTESTINAL PAIN 3 0.0003
748 GAIT DISTURBANCE 52 0.0003
749 SKIN HAEMORRHAGE 4 0.0003
750 SLEEP DISORDER 19 0.0003
751 COLON CANCER 4 0.0003
752 BACTERIAL INFECTION 5 0.0003
753 EYE PRURITUS 9 0.0003
754 SKIN INFECTION 3 0.0003
755 ABDOMINAL PAIN 62 0.0003
756 PHOTOPHOBIA 5 0.0003
757 CHROMATURIA 6 0.0003
758 EYE INFECTION 3 0.0003
759 CHILLS 31 0.0003
760 MOBILITY DECREASED 19 0.0003
761 DERMATITIS CONTACT 3 0.0003
762 MICTURITION URGENCY 3 0.0003
763 INTERNAL HAEMORRHAGE 3 0.0003
764 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
765 PERIPHERAL SWELLING 40 0.0003
766 MADAROSIS 3 0.0003
767 VASCULITIS 3 0.0003
768 HAEMORRHOIDS 5 0.0003
769 BALANCE DISORDER 22 0.0003
770 HAEMATOCHEZIA 14 0.0003
771 BLOOD ALBUMIN DECREASED 2 0.0003
772 CEREBRAL HAEMORRHAGE 9 0.0003
773 ATRIAL FLUTTER 2 0.0003
774 WOUND 7 0.0003
775 SPINAL FRACTURE 5 0.0002
776 COLITIS ULCERATIVE 11 0.0002
777 GASTROINTESTINAL DISORDER 22 0.0002
778 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
779 PRODUCT PREPARATION ERROR 5 0.0002
780 PAIN 149 0.0002
781 PULMONARY HYPERTENSION 5 0.0002
782 RENAL INJURY 7 0.0002
783 CIRCULATORY COLLAPSE 4 0.0002
784 EATING DISORDER 5 0.0002
785 POOR QUALITY SLEEP 5 0.0002
786 PLATELET COUNT INCREASED 3 0.0002
787 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
788 ARTHRITIS 18 0.0002
789 FALL 76 0.0002
790 GASTRITIS 6 0.0002
791 IMMUNE SYSTEM DISORDER 3 0.0002
792 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
793 SARS-COV-2 TEST POSITIVE 3 0.0002
794 ADVERSE REACTION 3 0.0002
795 DYSPEPSIA 22 0.0002
796 GOUT 4 0.0002
797 THERAPY NON-RESPONDER 10 0.0002
798 ANAL INCONTINENCE 2 0.0002
799 DYSPNOEA 125 0.0002
800 TACHYPNOEA 3 0.0002
801 PALLOR 6 0.0002
802 ACUTE HEPATIC FAILURE 3 0.0002
803 WEIGHT INCREASED 49 0.0002
804 MYALGIA 37 0.0002
805 NIGHT SWEATS 7 0.0002
806 RHINORRHOEA 14 0.0002
807 DIVERTICULITIS 6 0.0002
808 APHONIA 3 0.0002
809 DEMENTIA 6 0.0002
810 HEPATIC CIRRHOSIS 4 0.0002
811 ARTERIOSCLEROSIS 2 0.0002
812 SINUS TACHYCARDIA 3 0.0002
813 ARRHYTHMIA 10 0.0002
814 SUBDURAL HAEMATOMA 3 0.0002
815 RECTAL HAEMORRHAGE 9 0.0002
816 INCREASED APPETITE 4 0.0002
817 HYPERSOMNIA 6 0.0002
818 PULMONARY FIBROSIS 4 0.0002
819 DEPRESSED MOOD 11 0.0002
820 AFFECT LABILITY 2 0.0002
821 PAIN IN EXTREMITY 61 0.0002
822 HERNIA 4 0.0002
823 CHOKING 4 0.0002
824 SKIN FISSURES 4 0.0002
825 KIDNEY INFECTION 4 0.0002
826 HYPERTENSION 43 0.0002
827 LOSS OF CONSCIOUSNESS 26 0.0002
828 URINARY INCONTINENCE 6 0.0002
829 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
830 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
831 EPILEPSY 6 0.0002
832 INSURANCE ISSUE 3 0.0002
833 SKIN BURNING SENSATION 14 0.0002
834 LYMPHOMA 3 0.0002
835 MUSCULOSKELETAL CHEST PAIN 3 0.0002
836 FEMUR FRACTURE 6 0.0002
837 RESPIRATORY TRACT INFECTION 5 0.0002
838 LETHARGY 11 0.0002
839 DISEASE RECURRENCE 9 0.0002
840 RESPIRATORY TRACT CONGESTION 3 0.0002
841 SOMNOLENCE 38 0.0002
842 SENSORY DISTURBANCE 3 0.0002
843 DYSARTHRIA 7 0.0002
844 HYPOGLYCAEMIA 9 0.0002
845 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
846 FAECES DISCOLOURED 4 0.0002
847 PRODUCT DISPENSING ERROR 4 0.0002
848 CARDIAC ARREST 15 0.0002
849 ILL-DEFINED DISORDER 11 0.0002
850 CYTOMEGALOVIRUS INFECTION 3 0.0002
851 FEELING HOT 11 0.0002
852 PERICARDITIS 3 0.0002
853 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
854 EYE PAIN 10 0.0002
855 HEMIPARESIS 3 0.0002
856 HEART RATE IRREGULAR 4 0.0002
857 RED BLOOD CELL COUNT DECREASED 5 0.0002
858 MUSCULOSKELETAL DISCOMFORT 3 0.0002
859 SEIZURE 20 0.0002
860 DYSSTASIA 5 0.0002
861 COUGH 48 0.0002
862 CARDIAC DISORDER 16 0.0002
863 SWELLING 16 0.0002
864 BONE PAIN 10 0.0002
865 RHABDOMYOLYSIS 7 0.0002
866 RESPIRATORY DISORDER 5 0.0002
867 CONFUSIONAL STATE 27 0.0002
868 APHASIA 5 0.0002
869 END STAGE RENAL DISEASE 3 0.0002
870 CHEST PAIN 30 0.0002
871 LIMB DISCOMFORT 5 0.0002
872 EYE SWELLING 6 0.0002
873 APPLICATION SITE IRRITATION 2 0.0002
874 MIDDLE INSOMNIA 3 0.0002
875 FOOT FRACTURE 3 0.0002
876 EYE IRRITATION 9 0.0002
877 ARTHRALGIA 65 0.0002
878 HAEMATOMA 4 0.0002
879 DIPLOPIA 4 0.0002
880 JOINT STIFFNESS 4 0.0002
881 HAEMATOCRIT DECREASED 3 0.0002
882 OROPHARYNGEAL PAIN 14 0.0002
883 VISUAL ACUITY REDUCED 5 0.0002
884 ABDOMINAL DISCOMFORT 25 0.0001
885 PRODUCT ADMINISTRATION ERROR 3 0.0001
886 ILLNESS 15 0.0001
887 PERITONITIS 3 0.0001
888 MENTAL STATUS CHANGES 4 0.0001
889 DIZZINESS 69 0.0001
890 VISUAL IMPAIRMENT 17 0.0001
891 APATHY 2 0.0001
892 THERAPY CESSATION 7 0.0001
893 ABDOMINAL PAIN UPPER 28 0.0001
894 ABDOMINAL DISTENSION 14 0.0001
895 MYOCARDIAL INFARCTION 23 0.0001
896 MUSCLE TWITCHING 3 0.0001
897 PERICARDIAL EFFUSION 3 0.0001
898 PRODUCT PRESCRIBING ERROR 3 0.0001
899 HAEMORRHAGE 13 0.0001
900 DRUG INTOLERANCE 12 0.0001
901 CEREBROVASCULAR ACCIDENT 21 0.0001
902 MENTAL IMPAIRMENT 3 0.0001
903 PRESYNCOPE 3 0.0001
904 TREMOR 20 0.0001
905 EPISTAXIS 9 0.0001
906 ANAPHYLACTIC SHOCK 3 0.0001
907 UNRESPONSIVE TO STIMULI 3 0.0001
908 DEVICE DISLOCATION 5 0.0001
909 CONTUSION 11 0.0001
910 URTICARIA 19 0.0001
911 INSOMNIA 30 0.0001
912 OVERDOSE 24 0.0001
913 LIMB INJURY 3 0.0001
914 FLATULENCE 6 0.0001
915 CHRONIC KIDNEY DISEASE 8 0.0001
916 ANGINA PECTORIS 3 0.0001
917 PANCREATIC CARCINOMA 3 0.0001
918 TACHYCARDIA 9 0.0001
919 SYNCOPE 10 0.0001
920 THERAPEUTIC RESPONSE DECREASED 6 0.0001
921 HEAD INJURY 3 0.0001
922 HYPOACUSIS 4 0.0001
923 LACTIC ACIDOSIS 3 0.0001
924 SWELLING FACE 6 0.0001
925 PRODUCT STORAGE ERROR 8 0.0001
926 NEOPLASM MALIGNANT 6 0.0001
927 INFLUENZA 10 0.0001
928 FLUSHING 9 0.0001
929 DRUG INEFFECTIVE 116 0.0001
930 INCORRECT DOSE ADMINISTERED 20 0.0001
931 NASAL CONGESTION 5 0.0001
932 INFLUENZA LIKE ILLNESS 7 0.0001
933 HOSPITALISATION 13 0.0001
934 WHEEZING 5 0.0001
935 BLOOD GLUCOSE DECREASED 4 0.0001
936 IRRITABILITY 5 0.0001
937 JOINT SWELLING 10 0.0001
938 RESTLESSNESS 3 0.0001
939 NASOPHARYNGITIS 15 0.0001
940 BRONCHITIS 6 0.0001
941 HALLUCINATION 6 0.0001
942 FEELING ABNORMAL 19 0.0001
943 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
944 SPEECH DISORDER 4 0.0001
945 DRUG INTERACTION 12 0.0001
946 HYPERSENSITIVITY 14 0.0001
947 DISTURBANCE IN ATTENTION 4 0.0001
948 BLINDNESS 3 0.0001
949 LUNG NEOPLASM MALIGNANT 3 0.0001
950 ARTHROPATHY 4 0.0001
951 NECK PAIN 4 0.0001
952 WITHDRAWAL SYNDROME 3 0.0001
953 RHEUMATOID ARTHRITIS 8 0.0001
954 ANXIETY 20 0.0001
955 HYPERHIDROSIS 9 0.0001
956 PSORIASIS 9 0.0001
957 PALPITATIONS 8 0.0001
958 ANGIOEDEMA 3 0.0001
959 THROAT IRRITATION 3 0.0001
960 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
961 ACNE 5 0.0001
962 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
963 COMA 3 0.0001
964 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
965 AMNESIA 4 0.0001
966 TREATMENT FAILURE 5 0.0001
967 COMPLETED SUICIDE 5 0.0001
968 FLUID RETENTION 3 0.0001
969 MEMORY IMPAIRMENT 8 0.0001
970 INJURY 4 0.0001
971 DERMATITIS ATOPIC 3 0.0001
972 THERAPY INTERRUPTED 4 0.0001
973 ADVERSE DRUG REACTION 5 0.0001
974 AGITATION 4 0.0001
975 ADVERSE EVENT 5 0.0001
976 HOT FLUSH 4 0.0001
977 SURGERY 3 0.0001
978 DISCOMFORT 3 0.0000
979 MUSCLE SPASMS 9 0.0000
980 HEADACHE 29 0.0000
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
982 DEPRESSION 10 0.0000
983 UNEVALUABLE EVENT 3 0.0000
984 CHEST DISCOMFORT 4 0.0000
985 SINUSITIS 4 0.0000
986 ANAPHYLACTIC REACTION 2 0.0000
987 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
988 MUSCULOSKELETAL STIFFNESS 3 0.0000
989 EMOTIONAL DISTRESS 4 0.0000
990 INJECTION SITE ERYTHEMA 4 0.0000
991 ASTHMA 3 0.0000
992 NO ADVERSE EVENT 3 0.0000